News
🌏 Asia-PacificLatest pharmaceutical news, drug approvals, and NMPA regulatory updates
Latest News
Disparities in Early Access to Innovative Therapies: A Global Overview
This article examines the disparities in early access to innovative therapies across major global markets, highlighting implications for stakeholders.
UK Clinical Trials in Oncology: Actions Driving Impact
This article discusses the recent developments in UK clinical trials focused on oncology and their potential impact on the pharmaceutical landscape.
Innovative Oncology Pharma Companies in China: A Look Ahead
This article highlights three of China's most innovative pharmaceutical companies in oncology, focusing on their recent developments and market implications.
Biomarkers and Digital Technologies Transforming Oncology in Asia
This article discusses the transformative role of biomarkers and digital technologies in oncology care in Asia, focusing on anticipated drug approvals by 2026.
Asia Pacific eClinical Solutions Market Report 2025-2030: Key Insights
The Asia Pacific eClinical Solutions Market Report for 2025-2030 reveals critical insights into clinical trials and investment opportunities for stakeholders. This report is essential for BD teams, investors, and analysts.
Innovent Biologics and Pfizer: A $10.5B Oncology Partnership
Innovent Biologics has signed a landmark $10.5 billion deal with Pfizer to conduct 12 cancer drug trials. This partnership is set to significantly impact the oncology market.
Regulatory Round-Up: Drug Approvals on April 20, 2026
This article provides a comprehensive overview of drug approvals announced on April 20, 2026, highlighting key implications for business development teams and investors. Stay informed about the latest regulatory changes that could impact your strategies.
Onconic Therapeutics' Jakubo Enters Phase 3 Clinical Trials in China
Onconic Therapeutics has announced that its drug Jakubo has entered Phase 3 clinical trials in China. This development may have significant implications for investors and pharmaceutical teams.
Clinical Trials Market in Oncology: Size and Growth Insights for 2034
The oncology clinical trials market is poised for significant growth by 2034. This article delves into market size, share, and implications for stakeholders.
PREMIA and Lind Expand AI-Powered Clinical Trial Screening Across Asia-Pacific
PREMIA and Lind are set to revolutionize clinical trial screening in the Asia-Pacific region through AI technology, presenting significant investment opportunities. This expansion is poised to reshape competitive dynamics in the pharmaceutical industry.
Global Drug Discovery Market to Exceed $174.92 Billion by 2035
The global drug discovery market is set to surpass USD 174.92 billion by 2035, highlighting significant growth opportunities for investors and pharmaceutical teams. This article explores the implications of this market expansion.
Middle East Pharma Markets: Strategic Growth at API China 2026
The Middle East pharma markets are emerging as a strategic growth corridor, highlighted at API China 2026. This article analyzes the implications for business development teams and investors.
Sun Pharma's USD11.75bn Acquisition of Organon: Market Analysis
Sun Pharma's recent acquisition of Organon for USD11.75bn marks a significant shift in the pharmaceutical landscape. This article analyzes the market implications and investment opportunities.
Exosome-based Therapeutics Market Insights: 2033 Industry Report
The exosome-based therapeutics market is poised for significant growth by 2033, driven by innovative clinical trials. This article outlines key developments and their implications.
Medical Advances Soar With APAC's Clinical Trial Growth in Oncology
The APAC region is witnessing a significant surge in clinical trials, particularly in oncology, leading to groundbreaking medical advances. This growth presents unique opportunities for investors and pharmaceutical teams.
Regulatory Strategy Reimagined: Trends Accelerating Drug Development
This article examines three emerging trends in regulatory strategies that are accelerating drug development, providing insights for BD teams and investors.
AI Tools Transforming Clinical Trials in Life Sciences
AI tools are increasingly being adopted by life sciences companies to enhance clinical trials. This article explores the latest developments and their implications for the industry.
Brenus Pharma's STC-1010 IND Application Accepted by FDA
Brenus Pharma has announced the FDA's acceptance of its IND application for STC-1010 in MSS metastatic colorectal cancer. This development could significantly impact the competitive landscape and investment opportunities.
India Strengthens Vietnam Relations Amid Regional Diplomacy
India's recent diplomatic upgrades with Vietnam signal a strategic shift in regional relations, impacting the pharmaceutical market landscape. This article analyzes the potential implications for business development teams and investors.
Immunotherapy Boom Fuels PET/CT Imaging Demand in Australia
The surge in immunotherapy is significantly impacting PET/CT imaging demand in Australia's oncology sector. This article delves into the implications for pharmaceutical teams and investors.